The Manufacturers of Roundup are Replacing the Original Formula in All U.S. Retail Stores

In 2021, Bayer had announced plans to replace the original Roundup formula in U.S. retail stores with a safer alternative containing different ingredients, beginning in 2023. Today, shoppers are reporting that a new formula of Roundup, labeled with “Exclusive Formula” on the bottle, has finally started hitting the shelves.

This decision was part of Bayer’s overall Five-Point Plan to lessen the impact of current and future Roundup lawsuits. Prior to this 2021 announcement, Bayer and Monsanto had already lost three major Roundup trials between 2018 and 2019, owing nearly $2.5 billion in damages before appeal. Taking action to mitigate the consequences of future lawsuits was essential for the merged companies if they wanted to navigate the thousands of claims still waiting to be settled.

The primary active ingredient in the original Roundup formula, glyphosate, has been connected to several health issues, particularly certain types of cancer like Non-Hodgkin’s Lymphoma and other blood cancers. In response to these concerns, Bayer and Monsanto announced that they would be removing glyphosate from their consumer Roundup products.

According to the official Five-Point Plan, Bayer and Monsanto would be transitioning the “manufacturing of [their] glyphosate products in the U.S. residential Lawn & Garden market to new formulations that have different active ingredients.” 

As of spring 2024, this transition has only been partially implemented, with some regions of the country still awaiting the change. The reformulation of Roundup will only apply to products sold in U.S. retail outlets for residential and garden use. The companies have no intention of altering the Roundup products sold for industrial purposes or in international markets, meaning that these formulas will continue to include glyphosate.

Bayer insisted that its glyphosate-based products are safe for use and that the formula change should not be considered as an acknowledgment of fault or culpability. Rather than accepting any degree of responsibility for the lawsuits against them, Bayer criticized the U.S. mass tort system for enabling individuals diagnosed with blood cancer to pursue claims against the Roundup manufacturer without having to pay for upfront legal costs.

Considering these statements and the companies’ unwillingness to reformulate Roundup for industrial and international markets, it appears that Bayer and Monsanto’s primary concerns lie in maintaining profitability and avoiding further legal entanglements, rather than prioritizing the potential health and safety risks posed by their products to consumers.

If you developed Non-Hodgkin’s Lymphoma or a related type of lymphoma or leukemia after being exposed to Roundup, there is still time to file a claim against Bayer and Monsanto to receive significant compensation. If your diagnosis occurred within the last 20 years, then you may qualify to receive a free case review and take the first step towards filing a Roundup claim. 

To see if you can join the lawsuit and receive a settlement, take our 2-minute Roundup eligibility survey.